NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

OBGYN & Reproduction Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Polycystic Ovarian Syndrome



New polycystic ovarian syndrome research from B. Kumbak et al outlined



June 22nd, 2009

In this recent report, researchers in Istanbul, Turkey conducted a study "To evaluate the effect of metformin addition during ovarian hyperstimulation on cycle parameters and outcome of in vitro fertilization (IVF) treatment in polycystic ovary syndrome (PCOS) patients with a body mass index (BMI) 28 kg/m2. Retrospective review of patients' records."

"Istanbul Memorial Hospital Assisted Reproductive Treatment Unit. A total of 339 non-obese PCOS patients undergoing IVF were evaluated according to the supplementation of metformin. Cycle parameters and IVF outcomes of 220 patients given metformin were compared to those of 119 patients treated without metformin....


Source: OBGYN & Reproduction Week (2009-06-22)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login